01
Overview Modified Simiao Yong'an Soup is a traditional Chinese medicine (TCM) formula derived from the classic Simiao Yong'an Decoction. It is currently under investigation for the treatment of non-infectious uveitis. The base formula, Simiao Yong'an Decoction, is recognized for its multi-targeted therapeutic actions, including anti-inflammatory, anti-apoptotic, and immunomodulatory effects. It has been shown to modulate various signaling pathways involved in inflammation, cell survival, and angiogenesis. This herbal preparation is typically administered orally.
Other names Modified Simiao Yong'an Soup Recipe Granules Si-Miao-Yong-An Decoction SMYAD 02
Targets TLR4 (Toll-like receptor 4) VEGFA (Vascular endothelial growth factor A) MAPK3 (Mitogen-activated protein kinase 1) PDGFRB (Platelet-derived growth factor receptor beta) TGFB1 (Transforming growth factor Beta-1 proprotein) NF-κB CXCL2 (C-X-C motif chemokine ligand 2) ICAM1 (Intercellular Adhesion Molecule 1) IL8 (C-X-C Motif Chemokine Ligand 8) VEGFR2 (Vascular endothelial growth factor receptor 2) AGER (RAGE) AKT (RAC-alpha serine/threonine-protein kinase) JAK1 (Janus kinase 1) HDAC1 (Histone Deacetylase 1) HIF1A (Hypoxia-inducible factor 1-alpha) CCND1 (Cyclin D1) IL-6 (Interleukin 6) CCL2 (C-C motif chemokine 2) CXCL1 (C-X-C motif chemokine ligand 1) FGF2 PI3K (Phosphoinositide-3-kinase regulatory subunit 6) VCAM1 (Vascular cell adhesion molecule 1) CDK4 (Cyclin-dependent kinase 4) PDE5 (Phosphodiesterase 5A) PPARG (Peroxisome proliferator-activated receptor gamma) MMP9 (Matrix metalloproteinase-9) IL1B (Interleukin-1 beta) TNFA (Tumor necrosis factor alpha (soluble)) NOX4 (NADPH oxidase 4) ATM (Ataxia telangiectasia mutated protein) Beyond the preview
Go deeper on Modified Simiao Yong'an Soup. Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials Full profile access Follow clinical development from study design and recruitment through results.
Trial phase Status Readouts Indications & development Full profile access Explore development by indication, patient population, and geography.
Indications Development status Countries Licensing & deals Full profile access Trace asset ownership, licensing agreements, and commercial partnerships.
Partners Deal terms Milestones Patents & exclusivity Full profile access Explore the patent landscape and regulatory exclusivity around an asset.
Patents Expiration dates Exclusivity Competitive landscape Full profile access Compare development programs by target, modality, and indication.
Competing assets Targets Development stage Research & analysis Full profile access Connect source evidence and development news to your research questions.
Bring the full picture into focus. See how Gosset can support your research on Modified Simiao Yong'an Soup.
Explore the full profile